Autonomic Effects of Spinal Cord Stimulation in Spinal Cord Injury

NCT ID: NCT05960448

Last Updated: 2024-10-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-07-30

Study Completion Date

2026-07-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this interventional crossover study is to determine the effects of transcutaneous spinal cord stimulation (TSCS) on the ability to perform moderate exercise and regulate core body temperature in the chronic spinal cord injury community. The main questions it aims to answer are:

* What are the effects of active TSCS targeted for BP control on exercise endurance time and HR recovery during submaximal arm cycle ergometry (ACE) as compared to sham TSCS in participants with chronic, cervical SCI?
* What are the effects of active TSCS on Tcore responses to cool ambient exposure and on subjective reporting of thermal comfort and thermal sensitivity as compared to sham TSCS.

Participants will receive sham and active stimulation while using an arm bicycle or while in a cold room. Participants are free to participate in either the exercise phase, the cold room phase, or both phases of this study.

Please note that there no expected long term benefits of this study.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of the first part of this research study is to determine the effects of active transcutaneous spinal cord stimulation (TSCS) targeted for blood pressure (BP) control on exercise endurance time and heart rate (HR) recovery time during an arm cycle test. The results will help guide experimental studies aimed at improving exercise, rehabilitation, health, and longevity in the SCI population. If the participant chooses to participate in part one of this study, the participant will be asked to visit the laboratory for 2 visits that take about 3-4 hours each.

The purpose of part two of this study is to compare the effects of electricity being delivered through surface electrodes (sticky pads on the participants skin), called active transcutaneous spinal cord stimulation (TSCS), compared to sham TSCS (sticky pads with electricity initially turned on but then turned off) on the participants ability to 1) keep the participants body temperature stable and 2) feel comfortable, while in a cool environment (cool room at 64° F) for 90 minutes. The investigators will assess the participant thermal sensation by asking the participant if overall they feel cold, cool, neutral, warm, or hot and their comfort level by asking the participant to grade their thermal comfort (how comfortable or how uncomfortable they feel) when the participant is seated in a thermoneutral room (80° F) and again in the cool room with active TSCS compared to the cool room with sham TSCS. The results will help guide experimental studies aimed at improving health and longevity in the population with SCI. If the participant chooses to participate in this study, there will be 2 study visits that last about 3-4 hours each.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Orthostatic Hypotension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants
The participant will not know whether or not they are receiving spinal stimulation at any given session

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Transcutaneous Spinal Cord Stimulation

The transcutaneous spinal cord stimulation used in this experiment is specific to each participant as determined in a previous study. Possible parameters include biphasic or monophasic, Russian or Nonrussian, a variety of pulse widths, and location of stimulation (T7-8, T9-10,- T11-12, L1-2). The amplitude of the stimulation also depends on the results of the mapping study. This stimulation will be delivered 30 minutes at a time.

Group Type EXPERIMENTAL

Transcutaneous Spinal Cord Stimulation (TSCS)

Intervention Type OTHER

This is electrical stimulation delivered to the spinal cord through the skin and tissue using a cathode electrode to deliver the stimulation and anode electrodes to ground the circuit.

Sham Transcutaneous Spinal Cord Stimulation

The sham stimulation will follow the above parameters but will only be delivered for a minute rather than the full 30 minutes.

Group Type SHAM_COMPARATOR

Sham Transcutaneous Spinal Cord Stimulation

Intervention Type OTHER

This is designed to appear like transcutaneous spinal cord stimulation without actually delivering the stimulation.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Transcutaneous Spinal Cord Stimulation (TSCS)

This is electrical stimulation delivered to the spinal cord through the skin and tissue using a cathode electrode to deliver the stimulation and anode electrodes to ground the circuit.

Intervention Type OTHER

Sham Transcutaneous Spinal Cord Stimulation

This is designed to appear like transcutaneous spinal cord stimulation without actually delivering the stimulation.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

transcutaneous spinal stimulation (TSS) Sham Transcutaneous Spinal Stimulation Placebo Transcutaneous Spinal Stimulation Placebo Transcutaneous Spinal Cord Stimulation

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* You are above the age of 18 years old
* You have an SCI between C3-T6
* You have been injured longer than 1 year
* You participated in a prior experiment "Targeted Transcutaneous Spinal Cord Stimulation to Restore Autonomic Cardiovascular Health in Individuals with Spinal Cord Injury"
* You have an American Spinal Injury Association injury classification scale (AIS) A, B, C
* Your prescription medications have not changed for at least 30 days

Exclusion Criteria

* You have a history of seizures
* You have an acute illness or infection
* You have diabetes
* You have untreated thyroid disease
* You have a neurological condition other than SCI (Alzheimer's disease, dementia, stroke, multiple sclerosis, Parkinson's disease, etc.)
* You have a history of heart or vascular disease (coronary artery disease, congestive heart failure, peripheral artery disease,)
* You have a history of moderate or severe head trauma (TBI) or diagnosed with cognitive impairment
* You have a present or history of a psychological disorder
* You have contraindications to electricity over your spine
* You are dependent on a ventilator to breathe or have an open tracheostomy site
* You have a recent history of substance abuse (within the past 3 months)
* You have open wounds over the spine at the level targeted for stimulation
* You are pregnant
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

James J. Peters Veterans Affairs Medical Center

FED

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jill M. Wecht, Ed.D.

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jill M Wecht, EdD

Role: PRINCIPAL_INVESTIGATOR

James J. Peters Veterans Affairs Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

James J Peters VAMC

The Bronx, New York, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Matthew T Maher, MS

Role: CONTACT

(718) 584-9000 ext. 1706

Fiona E Fox, BS

Role: CONTACT

(718) 584-9000 ext. 3128

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Matthew T Maher, MS

Role: primary

718-584-9000 ext. 1706

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1727500

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Spinal Neurorehabilitation for Veterans With SCI
NCT07222046 NOT_YET_RECRUITING NA
Spinal Cord Stimulation and Training
NCT05472584 RECRUITING NA